| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.50B | 3.36B | 3.17B | 2.83B | 2.96B | 2.19B |
| Gross Profit | 1.89B | 1.80B | 1.70B | 1.38B | 1.55B | 1.09B |
| EBITDA | 731.58M | 719.12M | 696.64M | 464.09M | 627.01M | 295.21M |
| Net Income | 478.00M | 408.00M | 404.10M | 220.46M | 360.82M | 107.76M |
Balance Sheet | ||||||
| Total Assets | 4.40B | 4.07B | 3.95B | 3.54B | 3.66B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 595.26M | 816.83M | 697.69M | 447.72M | 638.00M | 746.71M |
| Total Debt | 768.60M | 924.22M | 852.20M | 788.19M | 833.09M | 1.03B |
| Total Liabilities | 1.33B | 1.35B | 1.31B | 1.21B | 1.30B | 1.41B |
| Stockholders Equity | 2.99B | 2.72B | 2.63B | 2.32B | 2.35B | 2.25B |
Cash Flow | ||||||
| Free Cash Flow | 487.63M | 379.37M | 416.04M | 53.36M | 369.27M | 303.87M |
| Operating Cash Flow | 579.73M | 521.19M | 575.76M | 238.72M | 510.72M | 376.32M |
| Investing Cash Flow | -298.13M | -145.47M | -154.96M | -227.55M | -142.65M | -47.32M |
| Financing Cash Flow | -398.21M | -227.70M | -173.64M | -201.79M | -452.12M | -32.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | €10.68B | 17.58 | 23.40% | 2.89% | 6.51% | 4.85% | |
74 Outperform | €5.18B | 10.92 | 17.42% | 3.73% | 6.87% | 18.37% | |
74 Outperform | €2.12B | 13.75 | 3.76% | 6.98% | 21.39% | -0.57% | |
74 Outperform | HK$22.89B | 39.61 | 24.57% | 0.68% | 13.58% | 24.59% | |
70 Neutral | HK$5.36B | 25.92 | 10.31% | 0.98% | 14.06% | 3.02% | |
63 Neutral | HK$11.48B | 240.00 | ― | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Modern Dental Group Limited reported record revenues, net profit, and EBITDA for the first half of 2025, driven by multi-dimensional strategies and digitalization in the dental industry. Despite a challenging macro-economic environment, the company increased its revenue by 7.8% to HK$1,834,814,000, with significant growth attributed to organic expansion and the acquisition of Hexa Ceram, Thailand’s largest dental laboratory. The company’s strong financial performance, including a 34.7% increase in net profit, underscores its solid fundamentals and strategic positioning to capitalize on emerging opportunities.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced an interim ordinary dividend of HKD 0.107 per share for the six months ending June 30, 2025. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders, with the payment scheduled for October 9, 2025, impacting stakeholders by providing a return on their investment.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced a board meeting scheduled for August 28, 2025, to review and approve the unaudited interim results for the first half of 2025. The meeting will also consider the declaration or payment of dividends, which could impact the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited announced a positive profit alert for the first half of 2025, with expected revenue growth between 4.3% and 8.7%, and a net profit increase between 30.1% and 37.6% compared to the same period in 2024. The growth is attributed to organic expansion, improved operational efficiency through digital solutions, favorable currency movements, and the strategic acquisition of Hexa Ceram, enhancing the company’s market position and financial performance.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.